Position in ALKS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,766,579
-$131,272,678 QoQ
Shares Held
262,721
-93.6% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 424 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. ALKS ranks #13 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in ALKS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,766,579 | 262,721 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $145,039,257 | 4,101,789 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $145,063,622 | 5,184,547 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $117,845,100 | 3,928,170 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $138,366,368 | 4,836,294 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $172,859,532 | 5,234,995 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $25,581,212 | 889,472 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,062,684 | 359,510 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $9,786,694 | 406,087 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $15,367,421 | 567,692 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $16,484,490 | 594,250 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $10,118,807 | 361,257 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,889,801 | 347,917 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,060,575 | 321,411 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $7,171,848 | 274,468 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,237,505 | 279,333 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,197,730 | 275,184 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,368,748 | 166,049 | Shares | Defined | 2022-05-11 | |
| 2021-06-30 | $3,252,626 | 132,652 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,365,564 | 73,103 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $27,171 | 1,362 | Shares | Defined | 2021-02-19 | |
| 2020-03-31 | $107,255 | 7,438 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||